This update is fascinating. As the flu season in the northern hemisphere approaches its interesting to note that in Australia the dominant viruses have been of the B subtype. Currently most vaccines in the northern hemisphere only protect against one B virus, although a new vaccine which protects against two is available and the Australian government is now switching to this. It seem highly likely that Northern Hemisphere governments will have to follow suit.
http://www.who.int/influenza/surveillance_monitoring/updates/latest_update_GIP_surveillance/en/
hVIVO is the new name of Retroscreen Virology! (from 15 April 2015). hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
No comments:
Post a Comment